ReP USP - Resultado da busca

Artigo de periodico
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial (2015)
Brunner, Hermine I.; Ruperto, Nicolino; Zuber, Zbigniew; Keane, Caroline; Harari, Olivier; Kenwright, Andrew; Lu, Peng; Cuttica, Ruben; Keltsev, Vladimir; Xavier, Ricardo M.; Calvo, Inmaculada; Nikishina, Irina; Rubio-Pérez, Nadina; Alexeeva, Ekaterina; Chasnyk, Vyacheslav; Horneff, Gerd; Opoka-Winiarska, Violetta; Quartier, Pierre; Silva, Clovis A.; Silverman, Earl; Spindler, Alberto; Baildam, Eileen; Gámir, M. Luz; Martin, Alan; Rietschel, Christoph; Siri, Daniel; Smolewska, Elzbieta; Lovell, Daniel; Martini, Alberto; De Benedetti, Fabrizio
Source: Annals of the Rheumatic Diseases. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS (EFICIÊNCIA;SEGURANÇA), ARTRITE REUMATOIDE, MÉTODO DUPLO-CEGO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNNER, Hermine I. et al. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, v. 74, n. 6, p. 1110-1117, 2015Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2014-205351. Acesso em: 25 jun. 2025.
APA
Brunner, H. I., Ruperto, N., Zuber, Z., Keane, C., Harari, O., Kenwright, A., et al. (2015). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, 74( 6), 1110-1117. doi:10.1136/annrheumdis-2014-205351
NLM
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351
Vancouver
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351
Artigo de periodico
Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years (2015)
Lovell, Daniel J.; Ruperto, Nicolino; Mouy, Richard; Paz, Eliana; Rubio-Pérez, Nadina; Silva, Clovis A.; Abud-Mendoza, Carlos; Burgos-Vargas, Ruben; Gerloni, Valeria; Melo-Gomes, Jose A.; Saad-Magalhaes, Claudia; Chavez-Corrales, J.; Huemer, Christian; Kivitz, Alan; Blanco, Francisco J.; Foeldvari, Ivan; Hofer, Michael; Huppertz, Hans-Iko; Deslandre, Chantal Job; Minden, Kirsten; Punaro, Marilynn; Block, Alan J.; Giannini, Edward H.; Martini, Alberto
Source: Arthritis and Rheumatology. Unidade: FM
Subjects: DOENÇA CRÔNICA, MEDICAÇÃO INTRAVENOSA, QUALIDADE DE VIDA, ARTRITE REUMATÓIDE JUVENIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOVELL, Daniel J. et al. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, v. 67, n. 10, p. 2759-2770, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf. Acesso em: 25 jun. 2025.
APA
Lovell, D. J., Ruperto, N., Mouy, R., Paz, E., Rubio-Pérez, N., Silva, C. A., et al. (2015). Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, 67( 10), 2759-2770. doi:10.1002/art.39234
NLM
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2025 jun. 25 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf
Vancouver
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2025 jun. 25 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf
Artigo de periodico
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis (2013)
Lazarevic, Dragana; Pistorio, Angela; Palmisani, Elena; Miettunen, Paivi; Ravelli, Angelo; Pilkington, Clarissa; Wulffraat, Nico M.; Malattia, Clara; Garay, Stella Maris; Hofer, Michael; Quartier, Pierre; Dolezalova, Pavla; Penades, Inmaculada Calvo; Ferriani, Virgínia Paes Leme; Ganser, Gerd; Kasapcopur, Ozgur; Melo-Gomes, José Antonio; Reed, Ann M.; Wierzbowska, Malgorzata; Rider, Lisa G.; Martini, Alberto; Ruperto, Nicolino
Source: Annals of the Rheumatic Diseases. Unidade: FMRP
Subjects: DERMATOPATIAS, DOENÇAS MUSCULOSQUELÉTICAS, REUMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAZAREVIC, Dragana et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Annals of the Rheumatic Diseases, v. 72, n. 5, p. 686-693, 2013Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2012-201483. Acesso em: 25 jun. 2025.
APA
Lazarevic, D., Pistorio, A., Palmisani, E., Miettunen, P., Ravelli, A., Pilkington, C., et al. (2013). The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Annals of the Rheumatic Diseases, 72( 5), 686-693. doi:10.1136/annrheumdis-2012-201483
NLM
Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VPL, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis [Internet]. Annals of the Rheumatic Diseases. 2013 ; 72( 5): 686-693.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1136/annrheumdis-2012-201483
Vancouver
Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VPL, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis [Internet]. Annals of the Rheumatic Diseases. 2013 ; 72( 5): 686-693.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1136/annrheumdis-2012-201483
Artigo de periodico
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial (2010)
Foell, Dirk; Wulffraat, Nico; Garay, Stella; Vojinovic, Jelena; Norambuena, Ximena; Gamir, María Luz; Consuegra, Julia García; Lepore, Loredana; Susic, Gordana; Corona, Fabrizia; Dolezalova, Pavla; Pistorio, Angela; Martini, Alberto; Ruperto, Nicolino; Roth, johannes; Wedderburn, Lucy R.; Wittkowski, Helmut; Frosch, Michael; Gerf, Joachim; Stanevicha, Valda; Mihaylova, Dimitrina; Ferriani, Virgínia Paes Leme; Tsakalidou, Florence Kanakoudi; Foeldvari, Ivan; Cuttica, Ruben; Gonzalez, Benito; Ravelli, Angelo; khubchandani, Raju; Oliveira, Sheila; Armbrust, Wineke
Source: JAMA: The Journal of the American Medical Association. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE JUVENIL, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOELL, Dirk et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, v. 303, n. 13, p. 1266-1273, 2010Tradução . . Acesso em: 25 jun. 2025.
APA
Foell, D., Wulffraat, N., Garay, S., Vojinovic, J., Norambuena, X., Gamir, M. L., et al. (2010). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, 303( 13), 1266-1273.
NLM
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2025 jun. 25 ]
Vancouver
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2025 jun. 25 ]
Artigo de periodico
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial (2010)
Vilca, Iris; Munitis, Pablo Garcia; Pistorio, Angela; Ravelli, Angelo; Buoncompagni, Antonella; Bica, Blanca; Campos, Lucia; Häfner, Renate; Hofer, Michael; Ozen, Seza; Huemer, Christian; Bae, Sang Cheol; Sztajnbok, Flavio; Arguedas, Olga; Foeldvari, Ivan; Huppertz, Hans Iko; Gamir, Maria Luz; Magnusson, Bo; Dressler, Frank; Uziel, Yosef; Rossum, Marion A. J. van; Hollingworth, Peter; Cawkwell, Gail; Martini, Alberto; Ruperto, Nicolino; Ferriani, Virgínia Paes Leme
Source: Annals of the Rheumatic Diseases. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE JUVENIL (TRATAMENTO), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILCA, Iris et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Annals of the Rheumatic Diseases, v. 69, n. 8, p. 1479-1483, 2010Tradução . . Disponível em: https://doi.org/10.1136/ard.2009.120840. Acesso em: 25 jun. 2025.
APA
Vilca, I., Munitis, P. G., Pistorio, A., Ravelli, A., Buoncompagni, A., Bica, B., et al. (2010). Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Annals of the Rheumatic Diseases, 69( 8), 1479-1483. doi:10.1136/ard.2009.120840
NLM
Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, Rossum MAJ van, Hollingworth P, Cawkwell G, Martini A, Ruperto N, Ferriani VPL. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial [Internet]. Annals of the Rheumatic Diseases. 2010 ; 69( 8): 1479-1483.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1136/ard.2009.120840
Vancouver
Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, Rossum MAJ van, Hollingworth P, Cawkwell G, Martini A, Ruperto N, Ferriani VPL. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial [Internet]. Annals of the Rheumatic Diseases. 2010 ; 69( 8): 1479-1483.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1136/ard.2009.120840
Artigo de periodico
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study (2008)
Ruperto, Nicolino; Ravelli, Angelo; Pistorio, Angela; Ferriani, Virgínia Paes Leme; Calvo, Immaculada; Ganser, Gerd; Brunner, Jurgen; Dannecker, Guenther; Silva, Clovis Artur Almeida da; Stanevicha, Valda; Cate, Rebecca Ten; Van Suijlekom-Smit, Lisette W. A.; Voygioyka, Olga; Fischbach, Michel; Foeldvari, Ivan; Hilario, Odete; Modesto, Consuelo; Saurenmann, Rotraud K.; Sauvain, Marie-Josephe; Scheibel, Iloite; Sommelet, Danièle; Tambic-Bukovac, Lana; Barcellona, Roberto; Brik, Riva; Ehl, Stephan; Jovanovic, Mirjana; Rovensky, Josef; Bagnasco, Francesca; Lovell, Daniel J.; Martini, Alberto
Source: Arthritis and Rheumatism. Unidade: FMRP
Subjects: DERMATOMICOSES, REUMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUPERTO, Nicolino et al. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis and Rheumatism, v. 59, n. 1, p. 4-13, 2008Tradução . . Disponível em: https://doi.org/10.1002/art.23248. Acesso em: 25 jun. 2025.
APA
Ruperto, N., Ravelli, A., Pistorio, A., Ferriani, V. P. L., Calvo, I., Ganser, G., et al. (2008). The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis and Rheumatism, 59( 1), 4-13. doi:10.1002/art.23248
NLM
Ruperto N, Ravelli A, Pistorio A, Ferriani VPL, Calvo I, Ganser G, Brunner J, Dannecker G, Silva CAA da, Stanevicha V, Cate RT, Van Suijlekom-Smit LWA, Voygioyka O, Fischbach M, Foeldvari I, Hilario O, Modesto C, Saurenmann RK, Sauvain M-J, Scheibel I, Sommelet D, Tambic-Bukovac L, Barcellona R, Brik R, Ehl S, Jovanovic M, Rovensky J, Bagnasco F, Lovell DJ, Martini A. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study [Internet]. Arthritis and Rheumatism. 2008 ; 59( 1): 4-13.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1002/art.23248
Vancouver
Ruperto N, Ravelli A, Pistorio A, Ferriani VPL, Calvo I, Ganser G, Brunner J, Dannecker G, Silva CAA da, Stanevicha V, Cate RT, Van Suijlekom-Smit LWA, Voygioyka O, Fischbach M, Foeldvari I, Hilario O, Modesto C, Saurenmann RK, Sauvain M-J, Scheibel I, Sommelet D, Tambic-Bukovac L, Barcellona R, Brik R, Ehl S, Jovanovic M, Rovensky J, Bagnasco F, Lovell DJ, Martini A. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study [Internet]. Arthritis and Rheumatism. 2008 ; 59( 1): 4-13.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1002/art.23248

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation